GLSI

Greenwich Lifesciences Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth↓ 0/10
  • Momentum↑ 9/10
Greenwich Lifesciences sales and earnings growth
GLSI Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -82.50%
  • FCF Y/Y↓ -13.51%
Greenwich Lifesciences gross and profit margin trends
GLSI Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↑ 1235.40%
Greenwich Lifesciences net debt vs free cash flow
GLSI Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Greenwich Lifesciences stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗